AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

DEVASTATED Nadia Sawalha fought back tears in an emotional video as she shared some heartbreaking news. Loose Women star ...

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as ...

As VERZENIO gains traction in early-stage treatments and broadens its approved uses, its revenue is expected to keep growing. While the global CDK4/6 inhibitor market remains highly competitive ...

San Antonio is one of 150 cities where the “U.S. Mail is Not for Sale – Day of Action” demonstration is planned. Spring is in the air, and it's time to get ready for nicer weather with some ...

According to a survey conducted by Intuit Credit Karma, 80% of Americans have seen a noticeable increase in the price of groceries in the last few years, especially after the pandemic. No matter ...

The company announced significant advancements in breast cancer treatment, with its drug Enhertu receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the ...

We found that when adding a 16-year-old driver to a parent’s policy, the average car insurance cost jumped from $2,603 per year to $5,011 per year. That’s an average increase of 103%.

Financial assistance may be available to help you with the cost of Kisqali. For additional information about Kisqali, including its use for certain kinds of breast cancer in adults, see this ...

When you buy through our links, Business Insider may earn an affiliate commission. Learn more The cost of Disney Plus has increased multiple times since the service's launch in 2019, but it ...

But the average solar panel system of 3.5kWp will cost around £7,000 to install, according to estimates from the Energy Saving Trust. The exact cost will vary, depending on the size of your home and ...

Credit: SewCreamStudio / Shutterstock. Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful ‘improvement’ in the DESTINY-Gastric04 Phase III trial, ...